This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Eirik Helseth: Innovator in Immunogenic Peptides
Introduction
Eirik Helseth is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of immunology, particularly through his work on immunogenic peptides and antibodies.
Latest Patents
Eirik Helseth holds 2 patents related to immunogenic peptides and their applications. His latest patents focus on immunogenic peptides containing amino acid residues that define a binding site to a CD4 receptor. These patents disclose antibodies to these peptides and methods for reducing the ability of a gp120 env protein to bind to CD4. Additionally, they describe methods of treatment and prophylaxis using these antibodies and peptides.
Career Highlights
Eirik Helseth is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in immunology. His work has implications for developing therapies that target specific proteins involved in immune responses.
Collaborations
Eirik has collaborated with prominent figures in the field, including Joseph G. Sodroski and William A. Haseltine. These collaborations have further enriched his research and contributions to immunology.
Conclusion
Eirik Helseth's innovative work in immunogenic peptides and antibodies showcases his commitment to advancing medical science. His patents and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile